Skip to main content
. 2017 Dec 5;12:3495–3501. doi: 10.2147/COPD.S151983

Figure 1.

Figure 1

ROC curves for ADAMTS-13 in predicting concealed CRF in COPD patients. The area under the ROC curve was 0.959. Sensitivity and specificity at an ADAMTS-13 cutoff of 318.72 ng/mL were 100% and 81.2%, respectively.

Abbreviations: ADAMTS-13, a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; CRF, chronic renal failure; ROC, receiver operating characteristic.